1,3,5-Triaza-7-phosphatricyclo[3.3.1.13,7]decane, 7-oxide
![]() |
- $76 - $161
- Product name: 1,3,5-Triaza-7-phosphatricyclo[3.3.1.13,7]decane, 7-oxide
- CAS: 53597-70-9
- MF: C6H12N3OP
- MW: 173.15
- EINECS:
- MDL Number:MFCD02693111
- Synonyms:1,3,5-Triaza-7-phosphaadamantane-7-oxide;1,3,5-Triaza-7-phosphatricyclo[3.3.1.13,7]decane, 7-oxide;1,3,5-Triaza-7-phosphaadamantane-7-oxide 97%;(1s,3s,5s)-1,3,5-Triaza-7-phosphaadamantane7-oxide
3 prices
Selected condition:
Brand
- AK Scientific
- Sigma-Aldrich
Package
- 500mg
- 1g
- ManufacturerAK Scientific
- Product number0971AQ
- Product description1,3,5-Triaza-7-phosphaadamantane-7-oxide
- Packaging500mg
- Price$140
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product number740861
- Product description1,3,5-Triaza-7-phosphaadamantane-7-oxide 97%
- Packaging500mg
- Price$76
- Updated2022-05-15
- Buy
- ManufacturerSigma-Aldrich
- Product number740861
- Product description1,3,5-Triaza-7-phosphaadamantane-7-oxide 97%
- Packaging1g
- Price$161
- Updated2023-06-20
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 0971AQ | 1,3,5-Triaza-7-phosphaadamantane-7-oxide | 500mg | $140 | 2021-12-16 | Buy |
Sigma-Aldrich | 740861 | 1,3,5-Triaza-7-phosphaadamantane-7-oxide 97% | 500mg | $76 | 2022-05-15 | Buy |
Sigma-Aldrich | 740861 | 1,3,5-Triaza-7-phosphaadamantane-7-oxide 97% | 1g | $161 | 2023-06-20 | Buy |
Properties
Melting point :280-290°C
Boiling point :385.2±42.0 °C(Predicted)
Density :1.47±0.1 g/cm3(Predicted)
storage temp. :2-8°C
form :solid
pka :3.96±0.20(Predicted)
Boiling point :385.2±42.0 °C(Predicted)
Density :1.47±0.1 g/cm3(Predicted)
storage temp. :2-8°C
form :solid
pka :3.96±0.20(Predicted)
Safety Information
Symbol(GHS): |
![]() |
|||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | |||||||||||||||||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
Precautionary statements: |
|